Small Cell Lung Cancer Transformation as a Mechanism of Resistance to PD-1 Therapy in KRAS-Mutant Lung Adenocarcinoma: A Report of Two Cases.
作者信息
Iams Wade T, Beckermann Kathryn E, Almodovar Karinna, Hernandez Jennifer, Vnencak-Jones Cindy, Lim Lee P, Raymond Christopher K, Horn Leora, Lovly Christine M
机构信息
Department of Medicine, Division of Hematology-Oncology, Vanderbilt University Medical Center, Nashville, Tennessee; Vanderbilt-Ingram Cancer Center, Nashville, Tennessee.
Department of Medicine, Division of Hematology-Oncology, Vanderbilt University Medical Center, Nashville, Tennessee.
出版信息
J Thorac Oncol. 2019 Mar;14(3):e45-e48. doi: 10.1016/j.jtho.2018.11.031. Epub 2018 Dec 10.
Abstract
摘要
相似文献
1
Small Cell Lung Cancer Transformation as a Mechanism of Resistance to PD-1 Therapy in KRAS-Mutant Lung Adenocarcinoma: A Report of Two Cases.
J Thorac Oncol. 2019 Mar;14(3):e45-e48. doi: 10.1016/j.jtho.2018.11.031. Epub 2018 Dec 10.
2
Mutations and PD-1 Inhibitor Resistance in -Mutant Lung Adenocarcinoma.
Cancer Discov. 2018 Jul;8(7):822-835. doi: 10.1158/2159-8290.CD-18-0099. Epub 2018 May 17.
3
The superior efficacy of anti-PD-1/PD-L1 immunotherapy in KRAS-mutant non-small cell lung cancer that correlates with an inflammatory phenotype and increased immunogenicity.
Cancer Lett. 2020 Feb 1;470:95-105. doi: 10.1016/j.canlet.2019.10.027. Epub 2019 Oct 20.
4
Predictive value of oncogenic driver subtype, programmed death-1 ligand (PD-L1) score, and smoking status on the efficacy of PD-1/PD-L1 inhibitors in patients with oncogene-driven non-small cell lung cancer.
Cancer. 2019 Apr 1;125(7):1038-1049. doi: 10.1002/cncr.31871. Epub 2018 Dec 11.
5
Collagen promotes anti-PD-1/PD-L1 resistance in cancer through LAIR1-dependent CD8 T cell exhaustion.
Nat Commun. 2020 Sep 9;11(1):4520. doi: 10.1038/s41467-020-18298-8.
6
Efficacy of Immune Checkpoint Inhibitors in KRAS-Mutant Non-Small Cell Lung Cancer (NSCLC).
J Thorac Oncol. 2019 Jun;14(6):1095-1101. doi: 10.1016/j.jtho.2019.01.011. Epub 2019 Feb 6.
7
The Combination of MEK Inhibitor With Immunomodulatory Antibodies Targeting Programmed Death 1 and Programmed Death Ligand 1 Results in Prolonged Survival in Kras/p53-Driven Lung Cancer.
J Thorac Oncol. 2019 Jun;14(6):1046-1060. doi: 10.1016/j.jtho.2019.02.004. Epub 2019 Feb 13.
8
Concurrent RB1 and TP53 Alterations Define a Subset of EGFR-Mutant Lung Cancers at risk for Histologic Transformation and Inferior Clinical Outcomes.
J Thorac Oncol. 2019 Oct;14(10):1784-1793. doi: 10.1016/j.jtho.2019.06.002. Epub 2019 Jun 19.
9
Transformation of ALK rearrangement-positive adenocarcinoma to small-cell lung cancer in association with acquired resistance to alectinib.
Ann Oncol. 2016 May;27(5):953-5. doi: 10.1093/annonc/mdw032. Epub 2016 Jan 24.
10
A Case of ALK-Rearranged Adenocarcinoma with Small Cell Carcinoma-Like Transformation and Resistance to Crizotinib.
J Thorac Oncol. 2016 May;11(5):e55-e58. doi: 10.1016/j.jtho.2015.12.097. Epub 2015 Dec 29.
引用本文的文献
1
[Case Report: Histological Transformation to Atypical Carcinoid in RET Fusion-positive NSCLC Following Immune Therapy Resistance].
Zhongguo Fei Ai Za Zhi. 2025 May 20;28(5):400-404. doi: 10.3779/j.issn.1009-3419.2025.102.14.
2
Case Report: Transforming small cell lung cancer: two cases report and literature review.
Front Oncol. 2025 Apr 3;15:1573624. doi: 10.3389/fonc.2025.1573624. eCollection 2025.
3
Neuroendocrine Transformation as a Mechanism of Resistance to Targeted Lung Cancer Therapies: Emerging Mechanisms and Their Therapeutic Implications.
Cancers (Basel). 2025 Jan 15;17(2):260. doi: 10.3390/cancers17020260.
4
A Case of Primary Lung Adenocarcinoma With Recurrent Brain Metastasis due to Transformation to Small Cell Carcinoma During Adjuvant Atezolizumab Therapy.
Thorac Cancer. 2025 Jan;16(2):e15512. doi: 10.1111/1759-7714.15512. Epub 2024 Dec 27.
5
Potential therapeutic option for EGFR-mutant small cell lung cancer transformation: a case report and literature review.
Front Immunol. 2024 Aug 21;15:1439033. doi: 10.3389/fimmu.2024.1439033. eCollection 2024.
6
Small cell lung cancer transformations from non-small cell lung cancer: Biological mechanism and clinical relevance.
Chin Med J Pulm Crit Care Med. 2024 Feb 6;2(1):42-47. doi: 10.1016/j.pccm.2023.10.005. eCollection 2024 Mar.
7
Evolution and genotypic characteristics of small cell lung cancer transformation in non-small cell lung carcinomas.
J Natl Cancer Cent. 2021 Nov 8;1(4):153-162. doi: 10.1016/j.jncc.2021.11.001. eCollection 2021 Dec.
8
Anaplastic thyroid carcinoma transformation in a patient with advanced non-small cell lung cancer treated with PD-1 therapy: A case report.
Respir Med Case Rep. 2024 Jun 5;50:102070. doi: 10.1016/j.rmcr.2024.102070. eCollection 2024.
9
Brief Report: Comprehensive Clinicogenomic Profiling of Small Cell Transformation From -Mutant NSCLC Informs Potential Therapeutic Targets.
JTO Clin Res Rep. 2023 Dec 17;5(2):100623. doi: 10.1016/j.jtocrr.2023.100623. eCollection 2024 Feb.
10
Histological transformation into SCLC: An important resistance mechanism of NSCLC upon immunotherapy.
Front Immunol. 2023 Oct 30;14:1275957. doi: 10.3389/fimmu.2023.1275957. eCollection 2023.
本文引用的文献
1
Clonal History and Genetic Predictors of Transformation Into Small-Cell Carcinomas From Lung Adenocarcinomas.
J Clin Oncol. 2017 Sep 10;35(26):3065-3074. doi: 10.1200/JCO.2016.71.9096. Epub 2017 May 12.
2
Small cell lung cancer transformation during immunotherapy with nivolumab: A case report.
Respir Med Case Rep. 2017 Mar 29;21:52-55. doi: 10.1016/j.rmcr.2017.03.019. eCollection 2017.
3
Transformation from non-small-cell lung cancer to small-cell lung cancer: molecular drivers and cells of origin.
Lancet Oncol. 2015 Apr;16(4):e165-72. doi: 10.1016/S1470-2045(14)71180-5.
4
Small-cell carcinoma in the setting of pulmonary adenocarcinoma: new insights in the era of molecular pathology.
J Thorac Oncol. 2013 Oct;8(10):1265-71. doi: 10.1097/JTO.0b013e3182a407fa.
5
Cell of origin of small cell lung cancer: inactivation of Trp53 and Rb1 in distinct cell types of adult mouse lung.
Cancer Cell. 2011 Jun 14;19(6):754-64. doi: 10.1016/j.ccr.2011.04.019.
Zotero 插件